Pharma industry trends in 2015 revolve around increased competition and payer pressure. Check out this infographic for more insights.

1. Tougher competition and margin pressures create more challenges for
the pharma industry in 2015. Changes in the payer landscape and
practice centralization have turned pharmaceutical sales into an
increasingly B2B sale that requires salespeople and companies to
navigate different influencers and decision makers than in the past.
the 3.2 trillion dollar
US healthcare
sector has become
a huge market
M&A $ value
*including pending deals
Much of the merger
and acquisition
activities will help
pharma companies
to overcome weak
pipelines.
Approximately
different rare
diseases exist
today
References: Health Affairs, Phrma.org, Wall Street Journal,
Centers for Medicare & Medicaid Services,
PwC Health Research Institute,
Synygy provides Sales Operations as a Service™
, an innovative blend of sales operations
expertise and technology know-how. This enables sales organizations to rapidly adapt to
changes in strategy, markets, and priorities.
Find out more about Sales Operations Management solutions for the Pharmaceutical
industry at www.synygy.com
Or contact us directly to speak with one of our Consultants.
info@synygy.com +1 610.494.3300 x7900
About Synygy
Pharma Industry
Outlook in 2015
Pharma Industry
Outlook in 2015
Pharma Industry
Outlook in 2015
RISE OF SPECIALTY MARKETSRISE OF SPECIALTY MARKETSRISE OF SPECIALTY MARKETS
INCREASED PAYER PRESSUREINCREASED PAYER PRESSUREINCREASED PAYER PRESSURE
FOCUS ON ANALYTICSFOCUS ON ANALYTICSFOCUS ON ANALYTICS
PRIVACY & STRONG INFO SECURITYPRIVACY & STRONG INFO SECURITYPRIVACY & STRONG INFO SECURITY
CHALLENGES IN THE SALES LANDSCAPECHALLENGES IN THE SALES LANDSCAPECHALLENGES IN THE SALES LANDSCAPE
M&A FRENZY EXPECTED TO GROWM&A FRENZY EXPECTED TO GROWM&A FRENZY EXPECTED TO GROW
PHARMACEUTICAL MARKET TRENDSPHARMACEUTICAL MARKET TRENDSPHARMACEUTICAL MARKET TRENDS
Americans are
affected by
rare diseases
More than 450
orphan drugs
are in development
In the US
80 million millennials
will help propel a
new health economy
1/10
Rise of ACOs: Hundreds of new Accountable Care
Organizations (ACO) continue to join Medicare
Shared Savings Program
Decreasing access to prescribers–
42% of practices with 10 or more
docs are no-see offices
Sunshine Act and PhRMA Code
impact sales
37% US consumers trust their
doctor less if the doctor is receiving
pharmaceutical payments
EXPERT TIP
Localize targets
and take advantage
of data proliferation!
2011 2012
TotalACOs
2013 2014 2015
2015
2013
2014
52% of US clinicians
are comfortable with
mobile apps and
devices monitoring
vital signs
Consumers are also
ready to embrace
high-tech, personal
medical kit devices
monitoring vital signs
Digital patient
data shared
along the
patient pathway
73% of US consumers
consider data security
more important
than the ability to
easily access it
744744
6464
Payer Integration into health systems
Aggressive push towards generics made
possible by patent expirations
Real World Evidence (RWE) and actual outcomes
data will drive contracting and payer access
Large pharma
companies embrace
big data
Pulling together data
sources in ways companies
couldn’t before
Need for the right
combination of
new technology,
subject matter expertise,
and business context
Strong analytics
help companies
mine big data
over $152.8 billion*
Data proliferation
leads to deeper
insights that drive
decision making
for brand teams,
medical & sales
More pharma targeting tips in
Synygy’s dedicated whitepaper